DVAHealthcaredavita.com
| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $3.29B | $3.22B | $3.38B | $3.42B | $3.62B | $3.42B | $3.55B | $3.58B | ▲ +4.6% |
| Gross profitnever filed | — | — | — | — | — | — | — | — | — |
| Operating income | $565.36M | $438.94M | $537.84M | $505.77M | $561.07M | $481.89M | $579.00M | $499.25M | ▼ -1.3% |
| Net income | $259.33M | $162.92M | $199.34M | $150.33M | $234.22M | $197.53M | $265.40M | $222.93M | ▲ +48.3% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 2.00 $ | 2.58 $ | 2.04 $ | — | 2.87 $ | 4.02 $ | 3.40 $ | ▲ +66.7% |
| Margins (% of revenue) | |||||||||
| Gross | — | — | — | — | — | — | — | — | — |
| Operating | 17.2 % | 13.6 % | 15.9 % | 14.8 % | 15.5 % | 14.1 % | 16.3 % | 14.0 % | ▼ -0.8 pt |
| Net | 7.9 % | 5.1 % | 5.9 % | 4.4 % | 6.5 % | 5.8 % | 7.5 % | 6.2 % | ▲ +1.8 pt |
| Balance sheet | |||||||||
| Assets | $17.29B | $17.12B | $17.49B | $17.56B | $17.48B | $17.50B | $17.71B | $17.82B | ▲ +1.5% |
| Liabilities | $15.19B | $15.46B | $15.94B | $16.22B | $16.32B | $16.45B | $16.63B | $16.69B | ▲ +2.9% |
| Equity | $395.87M | −$6.55M | −$107.97M | −$304.23M | −$373.73M | −$476.34M | −$481.98M | −$358.47M | ▼ -17.8% |
| Cash | $794.93M | $438.78M | $708.42M | $705.96M | $676.44M | $644.24M | $668.96M | $495.63M | ▼ -29.8% |
| Capital | |||||||||
| Shares outstanding | 80.00M | 75.50M | 71.50M | 70.60M | 66.80M | 64.20M | 63.80M | 62.90M | ▼ -10.9% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.